Ethicon endosurgery sedation system receives approval in Canada and
10 May 2010
Ethicon Endo-Surgery's Sedasys System, a computer-assisted
personalized sedation (CAPS) system, has been granted EU and Canadian
approval for routine colonoscopy, and also for screening of the upper
gastrointestinal tract (EGD procedures) in the EU.
The System integrates drug delivery and patient monitoring to enable
propofol sedation personalized to each patient's needs.
"We are excited by these regulatory approvals and the
opportunities they provide to bring the Sedasys System to the
Canadian and European markets," said Karen Licitra, Company Group
Chair and Worldwide Franchise Chair, Ethicon Endo-Surgery.
"We believe the Sedasys System has the potential to improve the
sedation experience for patients and clinicians during routine
colonoscopy procedures, and we look forward to the launch of the
System in these markets, as early as the end of this year."
About colorectal cancer
Colorectal cancer, also known as colon cancer, is one of the
deadliest and most expensive diseases to treat. Colon cancer is the
second-leading cause of cancer-related deaths in Canada(i) and the
third-leading cause of cancer death in the European Union.(ii) It is
also the third-leading cause of cancer death in the United States,
afflicting nearly 150,000 new patients each year, and claiming the
lives of nearly 50,000 more.(iii)
Regular screening tests — such as colonoscopy — are the most
effective way to detect abnormal and potentially precancerous
growths in the colon or rectum. While there has been an increased
demand for colorectal screening, the screening rate remains well
below the American Cancer Society's 2015 goal of 75% of the eligible
Contributing factors to patient noncompliance with colonoscopy
screening include fear of pain or discomfort and a previous
unpleasant experience with an uncomfortable colonoscopy.
i) Canadian Cancer Society;
ii) P.Boyle, J.Ferlay, "Cancer incidence and mortality in Europe,
2004," Annals of Oncology (2005), 16(5); 481-488
iii) Colorectal Cancer Facts & Figures, American Cancer Society,